BRUKER CORPORATION Accumulated Other Comprehensive Income
BRUKER CORPORATION (BRKR) had Accumulated Other Comprehensive Income of -$79.50 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-02-27
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$79.50M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$79.20M.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$103.50M.
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$62.30M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-12-31 | -$79.50M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$79.20M 10-Q · filed 2025-11-05 |
| 2024-12-31 | -$103.50M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$62.30M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$44.00M 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$7.70M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $6.00M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$5.20M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $24.40M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $29.60M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $14.80M 10-K · filed 2024-02-29 |
| 2022-09-30 | -$92.10M 10-Q · filed 2022-11-04 |
| 2022-06-30 | -$49.30M 10-Q · filed 2022-08-05 |
| 2022-03-31 | -$17.10M 10-Q · filed 2022-05-06 |
| 2021-12-31 | -$8.20M 10-K · filed 2023-03-01 |
| 2021-09-30 | -$10.70M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $4.30M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$12.10M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.70M 10-K · filed 2022-02-28 |
| 2020-09-30 | -$5.20M 10-Q · filed 2020-11-06 |
| 2020-06-30 | -$13.50M 10-Q · filed 2020-08-07 |
| 2020-03-31 | -$23.30M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$25.50M 10-K · filed 2021-03-01 |
| 2019-09-30 | -$18.80M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $15.40M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $3.30M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $17.00M 10-K · filed 2020-03-27 |
| 2018-09-30 | $12.70M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $14.80M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $51.20M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $27.00M 10-K · filed 2019-03-01 |
| 2017-09-30 | $10.50M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$13.00M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$60.20M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$75.90M 10-K · filed 2018-03-16 |
| 2016-09-30 | -$15.40M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$28.70M 10-Q · filed 2016-08-05 |
| 2016-03-31 | -$11.80M 10-Q · filed 2016-05-06 |
| 2015-12-31 | -$44.20M 10-K · filed 2018-03-16 |
| 2015-09-30 | -$7.70M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $200.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | -$36.00M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $28.20M 10-K · filed 2018-03-16 |
| 2014-09-30 | $98.70M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $181.70M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $185.20M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $182.40M 10-K · filed 2017-03-01 |
| 2013-09-30 | $150.80M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $114.20M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $109.20M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $137.80M 10-K · filed 2016-02-29 |
| 2011-12-31 | $142.50M 10-K · filed 2015-02-27 |
| 2010-12-31 | $152.40M 10-K · filed 2014-02-27 |
| 2009-12-31 | $153.50M 10-K · filed 2013-02-28 |
| 2008-12-31 | $137.80M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |